Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-P Droz

Showing results (51-60 of 364) with videos related to

Pageof 37
Sort By:
Presse Medicale (Paris, France : 1983)|April 8, 1989
[Tissue complications of cisplatin extravasation]C Louvet, C Bouleuc, J P Droz
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of germ-cell tumors of poor prognosis and role of intensification with hematological support]J P Droz, S Culine, P Biron
British Journal of Haematology|September 1, 1978
Ways of expressing results of human bone marrow progenitor cell cultureC Parmentier, J P Droz, M Tubiana
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A reviewJ P Droz, A T van Oosterom
Bulletin Du Cancer|January 1, 1988
[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)]P Rougier, M Ychou, J P Droz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Inappropriate antidiuretic hormone secretion induced by ifosfamideS Culine, M Ghosn, J P Droz
Critical Reviews in Oncology/Hematology|February 13, 2001
Intensive and timely chemotherapy, the key of success in testicular cancerA Fléchon, S Culine, J P Droz
Critical Reviews in Oncology/Hematology|January 7, 2014
Occupational exposures in rare cancers: A critical review of the literatureB Charbotel, B Fervers, J P Droz
Nouvelle Revue Francaise D'Hematologie|November 1, 1974
[Karyotype studies in primary polycythemia vera (author's transl)]R Berger, C Parmentier, J P Droz
International Journal of Cancer|December 22, 1999
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experienceA Fléchon, P Biron, J P Droz
Pageof 37

Showing results (51-60 of 364) with videos related to

Sort By:
Pageof 37
Presse Medicale (Paris, France : 1983)|April 8, 1989
[Tissue complications of cisplatin extravasation]C Louvet, C Bouleuc, J P Droz
Presse Medicale (Paris, France : 1983)|November 16, 1996
[Chemotherapy of germ-cell tumors of poor prognosis and role of intensification with hematological support]J P Droz, S Culine, P Biron
British Journal of Haematology|September 1, 1978
Ways of expressing results of human bone marrow progenitor cell cultureC Parmentier, J P Droz, M Tubiana
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Treatment options in clinical stage I non-seminomatous germ cell tumours of the testis: a wager on the future? A reviewJ P Droz, A T van Oosterom
Bulletin Du Cancer|January 1, 1988
[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)]P Rougier, M Ychou, J P Droz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Inappropriate antidiuretic hormone secretion induced by ifosfamideS Culine, M Ghosn, J P Droz
Critical Reviews in Oncology/Hematology|February 13, 2001
Intensive and timely chemotherapy, the key of success in testicular cancerA Fléchon, S Culine, J P Droz
Critical Reviews in Oncology/Hematology|January 7, 2014
Occupational exposures in rare cancers: A critical review of the literatureB Charbotel, B Fervers, J P Droz
Nouvelle Revue Francaise D'Hematologie|November 1, 1974
[Karyotype studies in primary polycythemia vera (author's transl)]R Berger, C Parmentier, J P Droz
International Journal of Cancer|December 22, 1999
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experienceA Fléchon, P Biron, J P Droz
Pageof 37